{"id":"6e8d97d7ed3b","type":"article","url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","title":"Albuminurietesting bij hypertensie en diabetes: IPD meta-analyse","title_en":"Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium.","category":"preventie","category_label":"Preventie","professions":["cardioloog","huisarts","internist"],"tags":[],"journal":"Hypertension (Dallas, Tex. : 1979)","doi":"10.1161/HYPERTENSIONAHA.121.17323","source_url":"https://doi.org/10.1161/HYPERTENSIONAHA.121.17323","authors":["Jung-Im Shin","Alex R Chang","Morgan E Grams","Josef Coresh","Shoshana H Ballew","Aditya Surapaneni","Kunihiro Matsushita","Henk J G Bilo","Juan J Carrero","Gabriel Chodick","Kenn B Daratha","Simerjot K Jassal","Girish N Nadkarni","Robert G Nelson","Christoph Nowak","Nikita Stempniewicz","Keiichi Sumida","Jamie P Traynor","Mark Woodward","Yingying Sang","Ron T Gansevoort"],"significance":7,"published":"2021-09-01","source_date":"2021-09-01","image":"","kennis":["https://hartvaat.nl/kennis/lipiden/lpa-meten-wanneer-waarom/"],"congress":"","summary_en":"This individual participant data meta-analysis from a global consortium showed that albuminuria testing provides important prognostic information in patients with hypertension and diabetes, supporting routine albuminuria screening for cardiovascular and renal risk stratification.","created":"2026-07-03T10:29:21Z","updated":"2026-07-03T13:28:29Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Individuele patiëntdata meta-analyse naar albuminurietesting bij hypertensie en diabetes in een mondiaal consortium.","abstract_original":"[Figure: see text]."}